Gland Pharma Limited (GLAND.BO)

INR 1448.25

(0.35%)

Net Debt Summary of Gland Pharma Limited

  • Gland Pharma Limited's latest annual net debt in 2023 was -14.67 Billion INR , up 22.96% from previous year.
  • Gland Pharma Limited's latest quarterly net debt in 2024 Q2 was -25.25 Billion INR , down 0.0% from previous quarter.
  • Gland Pharma Limited reported annual net debt of -19.04 Billion INR in 2022, down -556.52% from previous year.
  • Gland Pharma Limited reported annual net debt of -2.9 Billion INR in 2021, up 40.41% from previous year.
  • Gland Pharma Limited reported quarterly net debt of -1.23 Billion INR for 2023 Q2, down 0.0% from previous quarter.
  • Gland Pharma Limited reported quarterly net debt of -14.67 Billion INR for 2023 FY, up 22.96% from previous quarter.

Annual Net Debt Chart of Gland Pharma Limited (2023 - 2017)

Historical Annual Net Debt of Gland Pharma Limited (2023 - 2017)

Year Net Debt Net Debt Growth
2023 -14.67 Billion INR 22.96%
2022 -19.04 Billion INR -556.52%
2021 -2.9 Billion INR 40.41%
2020 -4.86 Billion INR -197.78%
2019 -1.63 Billion INR 28.85%
2018 -2.29 Billion INR 37.17%
2017 -3.65 Billion INR 0.0%

Peer Net Debt Comparison of Gland Pharma Limited

Name Net Debt Net Debt Difference
Abbott India Limited -20.51 Billion INR 28.47%
Cipla Limited -3.15 Billion INR -364.972%
GlaxoSmithKline Pharmaceuticals Limited -674.11 Million INR -2076.597%
Kopran Limited 850.3 Million INR 1825.582%
Marksans Pharma Limited -4.29 Billion INR -241.609%
NGL Fine-Chem Limited 307.22 Million INR 4875.883%
Pfizer Limited -19.52 Billion INR 24.839%
Sanofi India Limited -3.87 Billion INR -278.649%
SMS Pharmaceuticals Limited 2.44 Billion INR 699.942%